The page is the record's research on the issuer — no analyst, no rating, no view. # Apnimed, Inc. (NASDAQ: APMD) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Apnimed, Inc., listed on NASDAQ under ticker APMD, with ISIN US03770Y1073. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 41 filings in the twelve months to 2026-11-08, across 16 filing days. By type, the record holds 21 directors' dealings, 13 regulatory filings, 4 prospectuses, 2 results and 1 ad hoc filing. The median gap between filing days is 17 days. The latest filing is dated 2026-11-04 and is a regulatory filing, 4 days before the record date. The NASDAQ median filing count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days. The sector median filing count is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover, as foreign private issuers and older filings carry none). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2026-07-29 and 2026-07-30. It holds no delisting and no name change. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and the outcome therefore cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001745648.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/APMD (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/APMD (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/APMD · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp